 |
|
zileuton
A synthetic derivative of hydroxyurea with antiasthmatic properties. The leukotriene inhibitor zileuton blocks 5-lipoxygenase, which catalyzes the formation of leukotrienes from arachidonic acid; causes bronchodilation; decreases bronchial mucous secretion and edema; and may prevent or decrease the symptoms of asthma. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| US brand name: | | Zyflo | | | | Abbreviation: | | ZLT | | | | Chemical structure names: | | - (+-)-N-Hydroxy-N-(1-benzo[b]thien-2-ylethyl)-urea
- N-(1-Benzo[b]thien-2-ylethyl)-N-hydroxyurea
| | |
|
|
